Novo Holdings A/s
Novo Holdings A/S is a leading holding and investment company headquartered in Copenhagen, Denmark, established in 1999. It manages the wealth and assets of the Novo Nordisk Foundation, one of the world's largest philanthropic foundations. The company is the controlling shareholder of Novo Nordisk A/S and Novonesis A/S, and oversees an extensive investment portfolio across life science, equities, bonds, real estate, infrastructure, and private equity. As of 2024, Novo Holdings had approximately 181 companies in its investment portfolio and employs a global team across Copenhagen, San Francisco, Boston, Singapore, and London. The firm serves the philanthropic, scientific, and social mission of the Novo Nordisk Foundation, focusing on health, sustainability, and the green transition.
Investment Strategy
Novo Holdings employs a diversified long-term investment approach with a strong focus on life sciences through direct investments in seed, venture, growth, and principal transactions. Their strategy also covers planetary health and green transition initiatives, targeting innovative technologies in biotechnology and biosolutions for societal and environmental impact. About 59% of the portfolio is dedicated to life science investments, while the remainder includes global capital investments such as public equities, fixed income, private equity (non-life sciences), real assets, and credit. The firm combines stable majority ownership in key group companies with broad exposure to growth opportunities in Europe, North America, and Asia, aiming for both strong financial returns and positive societal contributions.
Top Holdings
Equity Positions (28)
| Ticker | Security | Weight | Market Value | Shares | Avg Cost | Price | Change (QoQ) |
|---|---|---|---|---|---|---|---|
V VTI | VANGUARD INDEX FDS | 22.28% | $315.6M | 1,038,550 | $268.05 | $303.93 | +$30.2M |
B BN | BROOKFIELD CORP | 10.18% | $144.2M | 2,330,830 | $31.27 | $61.85 | +$22.0M |
A ASML | ASML HOLDING N V | 9.38% | $132.9M | 165,836 | $662.32 | $801.39 | +$23.0M |
C CRM | SALESFORCE INC | 6.36% | $90.0M | 330,187 | $200.91 | $272.69 | +$16.8M |
M MIRM | MIRUM PHARMACEUTICALS INC | 5.39% | $76.3M | 1,500,055 | $10.06 | $50.89 | +$8.8M |